LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000546.6:c.833C>A
TP53
· NP_000537.3:p.(Pro278His)
· NM_000546.6
GRCh37: chr17:7577105 G>T
·
GRCh38: chr17:7673787 G>T
Gene:
TP53
Transcript:
NM_000546.6
Final call
PS3
PP3_Moderate
PM2_Supporting
Variant details
Gene
TP53
Transcript
NM_000546.6
Protein
NP_000537.3:p.(Pro278His)
gnomAD AF
ClinVar
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
TP53 p.Pro278His has abnormal functional evidence, and the TP53 VCEP functional worksheet assigns PS3 for this amino acid substitution.
2
TP53 in silico assessment assigns c.833C>A as PP3_Moderate, with BayesDel 0.607821 and Class C65 supporting a deleterious missense effect.
3
SpliceAI predicts a max delta score of 0.00, which is below the TP53 splice-impact threshold of 0.2 and does not indicate a predicted splice effect.
4
The variant is absent from gnomAD v4.1, and absence from population databases is consistent with the TP53 PM2_Supporting threshold of less than 0.00003.
5
Using the generic ACMG/AMP combination rules as a fallback because explicit TP53 VCEP final Tavtigian score thresholds were not explicitly retrieved, PS3 with PP3_Moderate and PM2_Supporting supports a Likely Pathogenic classification.
Final determination:
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | PVS1 is not applicable because NM_000546.6:c.833C>A is a missense variant, not a null or canonical splice variant addressed by the TP53 PVS1 framework. |
cspec
vcep_p_v_s_1___f_l_o_w_c_h_a_r_t
|
| PS1 | Not assessed | PS1 was not assessed because no TP53 VCEP-classified pathogenic or likely pathogenic variant producing the same amino acid change was explicitly retrieved. |
cspec
|
| PS2 | Not assessed | PS2 was not assessed because no de novo data, parental testing, or proband point tally was provided. |
cspec
vcep_t_a_b_l_e___o_f___l_f_s___c_a_n_c_e_r_s___a_n_d___p_o_i_n_t_s___f_o_r___p_s_2___a_n_d___p_p_1___c_o_d_e___a_p_p_l_i_c_a_t_i_o_n
|
| PS3 | Met | The TP53 VCEP functional worksheet lists P278H with a final functional assignment of PS3. |
vcep_f_u_n_c_t_i_o_n_a_l___w_o_r_k_s_h_e_e_t
vcep_f_l_o_w_c_h_a_r_t___f_o_r___a_p_p_l_i_c_a_t_i_o_n___o_f___f_u_n_c_t_i_o_n_a_l___r_u_l_e___c_o_d_e_s
cspec
|
| PS4 | Not assessed | PS4 was not assessed because no germline proband-based Li-Fraumeni syndrome point data were retrieved. |
cspec
vcep_p_s_4___p_o_i_n_t_s___t_a_b_l_e
|
| PM1 | Not assessed | PM1 was not applied because codon 278 is not one of the TP53 codons with automatic PM1 at moderate strength, and the available hotspot evidence did not explicitly provide a cancerhotspots.org same-amino-acid count meeting the TP53 PM1 threshold. |
cspec
oncokb
|
| PM2 | Met | The variant is absent from gnomAD v2.1 and gnomAD v4.1, which is below the TP53 PM2_Supporting threshold of less than 0.00003. |
gnomad_v2
gnomad_v4
cspec
|
| PM3 | N/A | PM3 is not applicable under the TP53 specifications. |
cspec
|
| PM4 | N/A | PM4 is not applicable because this is a missense substitution rather than a protein length-changing in-frame indel or stop-loss variant. |
cspec
|
| PM5 | Not assessed | PM5 was not assessed because no explicitly retrieved TP53 VCEP-classified pathogenic or likely pathogenic alternate missense variant at codon 278 was available. |
cspec
|
| PM6 | N/A | PM6 is not applicable under the TP53 specifications. |
cspec
|
| PP1 | Not assessed | PP1 was not assessed because no segregation data or meiosis count was provided. |
cspec
vcep_t_a_b_l_e___o_f___l_f_s___c_a_n_c_e_r_s___a_n_d___p_o_i_n_t_s___f_o_r___p_s_2___a_n_d___p_p_1___c_o_d_e___a_p_p_l_i_c_a_t_i_o_n
|
| PP2 | N/A | PP2 is not applicable under the TP53 specifications. |
cspec
|
| PP3 | Met | The TP53 VCEP PP3/BP4 worksheet assigns c.833C>A (p.Pro278His) as PP3_moderate with BayesDel score 0.607821 and Class C65; SpliceAI max delta score is 0.00, which is below the 0.2 splice-impact threshold used in the TP53 in silico flowchart. |
vcep_p_p_3___b_p_4___c_o_d_e_s
vcep_f_l_o_w_c_h_a_r_t___f_o_r___a_p_p_l_i_c_a_t_i_o_n___o_f___p_p_3___2_c___b_p_4___2_c___a_n_d___b_p_7
spliceai
cspec
|
| PP4 | Not assessed | PP4 was not assessed because no low-VAF constitutional mosaicism observations were provided. |
cspec
|
| PP5 | N/A | PP5 is not applicable under the TP53 specifications. |
cspec
|
| BA1 | Not met | BA1 is not met because the variant is absent from gnomAD and therefore does not reach the TP53 BA1 filtering allele frequency threshold of at least 0.001. |
gnomad_v4
cspec
|
| BS1 | Not met | BS1 is not met because the variant is absent from gnomAD and therefore does not reach the TP53 BS1 threshold of filtering allele frequency at least 0.0003. |
gnomad_v4
cspec
|
| BS2 | Not assessed | BS2 was not assessed because no single-source dataset of unrelated cancer-free females aged at least 60 years carrying this variant was provided. |
cspec
|
| BS3 | Not met | BS3 is not met because the TP53 VCEP functional worksheet assigns PS3 rather than BS3 for P278H, consistent with abnormal functional evidence rather than retained function. |
vcep_f_u_n_c_t_i_o_n_a_l___w_o_r_k_s_h_e_e_t
cspec
|
| BS4 | Not assessed | BS4 was not assessed because no nonsegregation data in affected relatives with Li-Fraumeni syndrome-associated cancers were provided. |
cspec
|
| BP1 | N/A | BP1 is not applicable under the TP53 specifications. |
cspec
|
| BP2 | N/A | BP2 is not applicable under the TP53 specifications for this review. |
cspec
|
| BP3 | N/A | BP3 is not applicable under the TP53 specifications. |
cspec
|
| BP4 | Not met | BP4 is not met because the TP53 VCEP in silico worksheet assigns PP3_moderate, not BP4, for c.833C>A. |
vcep_p_p_3___b_p_4___c_o_d_e_s
cspec
|
| BP5 | N/A | BP5 is not applicable under the TP53 specifications. |
cspec
|
| BP6 | N/A | BP6 is not applicable under the TP53 specifications. |
cspec
|
| BP7 | N/A | BP7 is not applicable because this is a missense variant rather than a synonymous or qualifying intronic variant. |
cspec
vcep_f_l_o_w_c_h_a_r_t___f_o_r___a_p_p_l_i_c_a_t_i_o_n___o_f___p_p_3___2_c___b_p_4___2_c___a_n_d___b_p_7
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.